The Role of Ketamine in Treatment -
Neuro Glow
www.neuroglow.com
At least 10-20% of the patients suffering from depression meet the criteria for treatment-resistant depression (TRD). In the last decades, the essential role of glutamate in mood modulation has been hypothesized. Ketamine, a non-noncompetitive antagonist of the N-methyl-D-aspartate (NMDA) receptors, has been effective in both MDD and TRD.
www.neuroglow.com
Several (twenty-five) prospective single- or multiple dose open-label and randomized double-blind placebo- or active-controlled studies including a total of 399 patients reported data regarding the efficacy of ketamine in patients with TRD.
Communication is cCLINICAL PROSPECTIVE OPEN-LABEL AND RANDOMIZED DOUBLEBLIND STUDIES www.neuroglow.com
Ketamine has been shown to reduce the effects of Post Partum Depression (PPD). Because Ketamine has rapid onset, new mothers can find relief within hours rather than waiting weeks to figure out the appropriate dose of oral anti depressants. www.neuroglow.com
We provide evidence based and personalized treatments to each patient. Rest assured that you will be treated with the utmost compassion and care. Please call us to learn more about what we have to offer. www.neuroglow.com
READY TO BEGIN YOUR JOURNEY? Contact USPhone : 800-975-3859
Email :
[email protected]
Website: www.neuroglow.com Address : 4961 Long Prairie Rd Suite 110 Flower Mound TX , 75028
